Last reviewed · How we verify
NCT00001621
Evaluation and Treatment of Patients With Lung Disease Not Participating in Research
trial in Pulmonary Disease in 280 participants. Completed in 25 September 2020.
25 September 2020
Quick facts
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 280 |
| Start date | 12 February 1997 |
| Primary completion | 25 September 2020 |
| Estimated completion | 25 September 2020 |
| Sites | 1 location across United States |
Conditions studied
- Pulmonary Disease — all drugs for Pulmonary Disease →
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Who can join
Adults 8 to 99, any sex, with Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and treat patients with lung disease who do not meet the criteria for other research studies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00001621
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Disease
Currently open trials in the same condition.
- NCT07103499 — Abdominal and Core Exercises on Respiratory Functions in Obese and Overweight Women (COREBREATH) · NA · recruiting
- NCT06998550 — Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye · recruiting
- NCT04441151 — Evaluation of the Effect of Pulmonary Rehabilitation on Patients With High Flow Oxygen Therapy · NA · recruiting
- NCT07048678 — Evaluating the Impact of Preoperative Respiratory Exercises on Post-Surgical Pulmonary Outcomes RCT · NA · active not recruiting
- NCT06775106 — Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections · recruiting
Other National Heart, Lung, and Blood Institute (NHLBI) trials
Trials by the same sponsor.
- NCT07566494 — Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease · Phase 1 · not yet recruiting
- NCT07137455 — EDEN Intracardiac Electrogram Recording and Classifying System · NA · enrolling by invitation
- NCT05372627 — NHLBI-Emory Advanced Cardiac CT Reconstruction · not yet recruiting
- NCT07516379 — GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejecti · not yet recruiting
- NCT06948097 — Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fost · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00001621 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Heart, Lung, and Blood Institute (NHLBI)
- Last refreshed: 28 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00001621.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing